← FDA DRUG APPROVALS

FDA ANDA · ANDA040547

METHIMAZOLE

Sponsor: AIPING PHARM INC

APPLICATION
ANDA040547
TYPE
ANDA
ORIGINAL APPROVAL
2005-02-18
LATEST ACTION
2019-01-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription, Discontinued

Products

METHIMAZOLEPrescription
METHIMAZOLE 10MG · TABLET · ORAL
METHIMAZOLEDiscontinued
METHIMAZOLE 20MG · TABLET · ORAL
METHIMAZOLEPrescription
METHIMAZOLE 5MG · TABLET · ORAL
METHIMAZOLEDiscontinued
METHIMAZOLE 20MG · TABLET · ORAL

Approval history

2019-01-18Labeling · Supplement 11 · standardAP
2016-01-15Labeling · Supplement 9 · standardAP
2005-02-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →